Attached files

file filename
10-K - FORM 10-K - ENTEST BIOMEDICAL, INC.entb0129form10k.htm
EX-32.1 - EXHIBIT 32.1 - ENTEST BIOMEDICAL, INC.entb0129form10kex321.htm
EX-31.2 - EXHIBIT 31.2 - ENTEST BIOMEDICAL, INC.entb0129form10kex312.htm
EX-32.2 - EXHIBIT 32.2 - ENTEST BIOMEDICAL, INC.entb0129form10kex322.htm
EX-31.1 - EXHIBIT 31.1 - ENTEST BIOMEDICAL, INC.entb0129form10kex311.htm
EX-10.37 - EXHIBIT 10.37 - ENTEST BIOMEDICAL, INC.entb0129form10kex1037.htm
EXCEL - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R3.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R8.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R5.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R9.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R1.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R4.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R2.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R7.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R6.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R16.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R10.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R30.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R20.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R42.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R27.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R24.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R17.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R25.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R26.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R43.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R44.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R40.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R22.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R37.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R23.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R35.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R31.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R29.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R14.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R36.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R19.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R41.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R38.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R28.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R13.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R33.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R32.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R15.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R18.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R34.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R39.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R11.htm
EX-10.39 - EXHIBIT 10.39 - ENTEST BIOMEDICAL, INC.entb0129form10kex1039.htm
XML - IDEA: XBRL DOCUMENT - ENTEST BIOMEDICAL, INC.R12.htm
v2.4.0.6
STOCK TRANSACTIONS
12 Months Ended
Aug. 31, 2012
Equity [Abstract]  
STOCK TRANSACTIONS

NOTE 16. STOCK TRANSACTIONS

 

During the twelve months ended August 31, 2012 the Company issued 113,695,700 Common Shares in satisfaction of $374,959 in debt and accrued interest.

 

During the twelve months ended August 31, 2012 the Company issued 3,272,000 Common Shares for services rendered valued at $171,750.

 

During the twelve months ended August 31, 2012 the Company issued 2,500,000 Common shares for acquisition of intangible assets valued at $700,000.

 

During the twelve months ended August 31, 2012 the Company issued 6,274,726 Common Shares valued at $23,868 pursuant to contractual obligations contained in certain convertible notes outstanding.

 

During the twelve months ended August 31, 2012 the Company issued 75,000 shares of its Non Voting Convertible Preferred Stock for services rendered valued at $75,000.

 

On December 26, 2011 an employee of the Company consented to the cancellation of 15,000 common shares previously issued as compensation.

 

On December 29, 2011 75,000 common shares previously issued to the company’s former Chief Financial Officer were returned for cancellation by the Company. Of that amount 40,000 were subject to forfeiture and are cancelled pursuant to those forfeiture provisions at the company’s option and the company’s former Chief Financial Officer has consented to cancellation of the remaining 35,000 common shares.

 

During the Quarter ended May 31, 2012 a dividend of 3, 201,397 shares of Series B Preferred Stock was paid to the Company’s common shareholders of record as of February 21, 2012.

 

On April 3, 2012 the Company issued 50,000,000 shares of common stock to David R. Koos, the Company’s Chief Executive Officer, as a restricted stock award (“Bonus Shares”).David Koos may not offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (“Restricted Period”). In the event that, prior to the expiration of the Restricted Period, David Koos voluntarily ceases to be employed at the Company or is terminated for cause the Shares shall be forfeited.

 

On April 3, 2012 the Company issued 27,000,000 shares of common stock to seven employees as a restricted stock award (“Bonus Shares”).No employee may offer to sell, sell, transfer, pledge or otherwise dispose of the Bonus Shares prior to April 2, 2017 (“Restricted Period”).In the event that, prior to the expiration of the Restricted Period, any employee voluntarily ceases to be employed at the Company or is terminated for cause his or her Shares shall be forfeited.

 

On April 3, 2012 the Company issued 15,000,000 shares of common stock to a consultant as a restricted stock award (“Bonus Shares”).The recipient may not offer to sell, sell, transfer, pledge or otherwise dispose of the Shares prior to April 2, 2017 (“Restricted Period”). In the event that, prior to the expiration of the Restricted Period, the recipient declines to provide if requested to provide, or is unable to provide if requested to provide, consulting services to the Company of a nature that have been customarily provided by the recipient to the Company the Shares shall be forfeited.

 

On August 2, 2012 an employee of the Company consented to the cancelation of 15,000,000 common shares issued to her as a Restricted Stock Award.